Search - tctmd.com

Displaying 321 - 340 of 1412

Sort: Relevancy | Date

Presentation TCT 2019

Making the Case for… - Anatomic Considerations and Optimizing Procedural Outcomes With Case Presentations

Presenter: Stanley Chetcuti

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

Case Presentation

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Presenter: Davide Capodanno

September 26, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Presenter: Edip Gurol

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Presenter: Martin Leon

September 26, 2019

Presentation TCT 2019

Optimizing TAVR Technology: TAVR Case Video and Early Clinical Impressions

Presenter: Tamim Nazif

September 26, 2019

Presentation TCT 2019

The Vancouver 3M Pathway: Data Review, Practical Implementation, and the Importance of Patient-Centric Decision-Making

Presenter: Sandra Lauck

September 26, 2019

Presentation TCT 2019

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Presenter: Philippe Genereux

September 26, 2019

Presentation TCT 2019

Case Presentation: Low-Risk AS

Presenter: Amisha Patel

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Other Transcatheter Approaches to TR Reduction: Spacer, Leaflet Grasping, and Tricuspid Valve Replacement

Presenter: Susheel Kodali

September 26, 2019

Presentation TCT 2019

Annular Reduction and 3D ICE

Presenter: Charles Davidson

September 26, 2019

Presentation TCT 2019

Case #3: Resolution

Presenter: David Daniels

September 26, 2019

Presentation TCT 2019

The Surgeon’s Perspective of TR Treatment: Advantages of Transcatheter Therapy

Presenter: Robert Smith

September 26, 2019

Presentation TCT 2019

What Do We Really Know About Transcatheter Tricuspid Intervention?

Presenter: Francesco Maisano

September 26, 2019

Advertisement

Making the Case for… - Anatomic Considerations and Optimizing Procedural Outcomes With Case Presentations

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Case Presentation

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Remaining Data Gaps After the Low-Risk TAVR RCTs

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Optimizing TAVR Technology: TAVR Case Video and Early Clinical Impressions

The Vancouver 3M Pathway: Data Review, Practical Implementation, and the Importance of Patient-Centric Decision-Making

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Case Presentation: Low-Risk AS

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Other Transcatheter Approaches to TR Reduction: Spacer, Leaflet Grasping, and Tricuspid Valve Replacement

Annular Reduction and 3D ICE

Case #3: Resolution

The Surgeon’s Perspective of TR Treatment: Advantages of Transcatheter Therapy

What Do We Really Know About Transcatheter Tricuspid Intervention?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content